Drawing for JP

USPTO serial 79394495

JP

Reviewed by CopyMark Law Group

Reg. 7756986Status 700Registered
Filing date
Status date
Registration date
Apr 15, 2025
Examiner
PEISECKI, MARK A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason DeFrancesco

Jason DeFrancesco DeFrancescoLaw110 Dungannon Blvd., Ste 101Wilmington, NC 28403United States

Goods and services

ClassDescriptionStatusFirst use
040Processing services for active pharmaceutical ingredients and pharmaceutical intermediates, namely, custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical products to order and in accordance with a customer's requirements; manufacturing of bio-pharmaceutical materials for others; treatment of bio-pharmaceutical materials by means of particle size engineering processings; microencapsulation services for third parties, namely, chemical encapsulation and dispersion of hazardous chemicalsACTIVE—
042Providing medical and scientific research information in the field of pharmaceutical products; pharmaceutical research and development; medicine discovery services, namely research and development of medicines; pharmaceutical research and development services; technical and scientific advice relating to pharmacology; technical and scientific advice relating to pharmaceutical research; research and development of pharmaceutical products and medicines; inspection of pharmaceutical products for quality control; technical and scientific laboratory research in the field of pharmaceutical products; research in the field of pharmaceutical products; scientific research in the pharmaceutical field; pharmacological research services; medical and pharmacological research services; services for assessing the efficiency of pharmaceutical products, namely testing of pharmaceuticals; drug development for pharmaceutical use; development of pharmaceutical products; conducting preliminary evaluations in the field of new pharmaceutical products, namely, testing of pharmaceuticals; testing of pharmaceutical products; evaluation of the quality of pharmaceutical products; quality evaluation of chemical syntheses in the field of pharmaceuticals; technical consultancy services in the field of pharmaceuticals productsACTIVE—
044Consultant services relating to pharmaceutical and medical products, namely, medical and pharmaceutical consultation; provision of information in the pharmaceutical field relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consultant and information services relating to biopharmaceutical products, namely, pharmaceutical consultations; consultant and information services relating to pharmaceutical products, namely, pharmaceutical consultation; consultancy services relating to pharmaceutical products; pharmaceutical advice; dispensing of pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 22, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 31, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 31, 2025FIMPFINAL DISPOSITION PROCESSED—
Oct 10, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 16, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 5, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 5, 2024RFRRREFUSAL PROCESSED BY MPU—
Jul 16, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2024DOCKASSIGNED TO EXAMINER—
May 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 9, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
May 9, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance